Please provide your email address to receive an email when new articles are posted on . A phase 2 human challenge trial will measure time to recovery from dengue and determine effective doses of the ...
PARAMUS, N.J.--(BUSINESS WIRE)--PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback